AMMI Canada Practice Point: Updated recommendations for treatment of adults with symptomatic COVID-19 in 2023-2024

By sjmartinez • January 22, 2024

Grant JM, Lam J, Goyal SV, Lother S, Kassim SS, Lee SB, Chan J, Girouard G, Barrett L, Takaya S, Piszczek J, Vinh DC, Findlater AR, Saxinger L. AMMI Canada Practice Point: Updated recommendations for treatment of adults with symptomatic COVID-19 in 2023-2024. J Assoc Med Microbiol Infect Dis Can. 2024 Jan 16;8(4):245-252. doi: 10.3138/jammi-2023-12-07. PMID: 38250615; PMCID: PMC10797770.

Tags: anti-inflammatory medications, anti-microbial stewardship, anti-viral therapy, covid-19, gestion des antimicrobiens, Infectious Diseases, médicaments anti-inflammatoires, Publications, recommandations thérapeutiques, SARS-CoV-2, SRAS-CoV-2, traitement antiviral, treatment recommendations

First imported cases of MPXV Clade Ib from Goma, Democratic Republic of the Congo

Mukadi-Bamuleka D, Kinganda-Lusamaki E, Mulopo-Mukanya N, Amuri-Aziza A, O'Toole Á, Merritt S, Modadra-Madakpa B, Mutombo-Ndongala G, Vakaniaki EH, Kacita C, Maboko GL, Makangara-Cigolo JC, Ngimba[...]

Using generative artificial intelligence to identify central line-associated bloodstream infections

Morgan DJ, AlShanqeeti S, Coffey KC, Baghdadi JD, Goodman KE, Holman JL, Pineles L, Goedken CC, Firestone C, Branch-Elliman W; VA AI CLABSI study group.[...]

Lessons Learned: Quality Analysis of Optical Coherence Tomography in Neuromyelitis Optica

Salih H, Samadzadeh S, Bereuter C, Motamedi S, Chien C, Villoslada P, Stiebel-Kalish H, Asgari N, Mao-Draayer Y, Ringelstein M, Havla J, Peixoto MAL, Kim[...]